| Accession Number | 0000905148-26-000003 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 2, 2026 |
| Document Date | Dec 30, 2025 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, Head of Global Oncology Research and Development | American Depositary Shares | โ | Dec 30, 2025 | Exercise/Conversion | 21,000 | โ | โ | 63,178 | Direct | โ | View Details | |
President, Head of Global Oncology Research and Development | American Depositary Shares | โ | Dec 31, 2025 | Sale | 10,787 | $17.43 | $188,038.98 | 52,391 | Direct | โ | View Details | |
President, Head of Global Oncology Research and Development | Restricted Share Units | Derivative | Dec 30, 2025 | Exercise/Conversion | 21,000 | $0.00 | $0.00 | 42,000 | Direct | โ | View Details |